| Primary |
| Anticoagulant Therapy |
19.2% |
| Pancreatic Carcinoma Non-resectable |
17.5% |
| Antiplatelet Therapy |
16.2% |
| Thrombosis Prophylaxis |
5.0% |
| Neoplasm |
4.8% |
| Cerebrovascular Accident Prophylaxis |
4.0% |
| Transient Ischaemic Attack |
3.5% |
| Cerebrovascular Accident |
3.3% |
| Product Used For Unknown Indication |
3.2% |
| Cardiac Stress Test |
3.1% |
| Malignant Atrophic Papulosis |
3.1% |
| Kawasaki's Disease |
2.6% |
| Hypertension |
2.3% |
| Ischaemic Stroke |
2.3% |
| Myocardial Ischaemia |
2.3% |
| Maternal Exposure During Pregnancy |
2.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
| Scan Myocardial Perfusion |
1.4% |
| Atrial Fibrillation |
1.2% |
| Blood Pressure Increased |
1.2% |
|
| Gastrointestinal Haemorrhage |
10.9% |
| Vomiting |
10.9% |
| Cerebral Haemorrhage |
8.2% |
| Transient Ischaemic Attack |
7.5% |
| Neoplasm Recurrence |
5.4% |
| Upper Gastrointestinal Haemorrhage |
5.4% |
| Vitreous Haemorrhage |
5.4% |
| Cerebrovascular Accident |
4.8% |
| Drug Ineffective |
4.8% |
| Haemorrhage Intracranial |
4.8% |
| Haemorrhage |
4.1% |
| Thrombosis In Device |
4.1% |
| Melaena |
3.4% |
| Myocardial Infarction |
3.4% |
| Stomatitis |
3.4% |
| Cardiac Tamponade |
2.7% |
| Dyspnoea |
2.7% |
| Embolic Stroke |
2.7% |
| Large Intestinal Haemorrhage |
2.7% |
| Multi-organ Failure |
2.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
19.3% |
| Product Used For Unknown Indication |
12.0% |
| Antiplatelet Therapy |
9.2% |
| Anticoagulant Therapy |
8.9% |
| Hemiparesis |
6.8% |
| Adenocarcinoma Pancreas |
5.0% |
| Thrombosis Prophylaxis |
4.8% |
| Cerebrovascular Accident |
4.0% |
| Hypertension |
3.7% |
| Transient Ischaemic Attack |
3.3% |
| Asthma |
3.1% |
| Headache |
3.0% |
| Ischaemic Stroke |
2.8% |
| Peripheral Ischaemia |
2.6% |
| Kawasaki's Disease |
2.5% |
| Neoplasm |
2.3% |
| Acute Coronary Syndrome |
2.0% |
| Atrial Fibrillation |
2.0% |
| Coronary Artery Disease |
1.6% |
| Ill-defined Disorder |
1.2% |
|
| Renal Disorder |
11.0% |
| Ischaemic Stroke |
7.9% |
| Cerebrovascular Accident |
7.1% |
| Partial Seizures |
7.1% |
| Thrombocytopenia |
7.1% |
| Cerebral Haemorrhage |
5.5% |
| Feeling Abnormal |
5.5% |
| Weight Fluctuation |
5.5% |
| Convulsion |
4.7% |
| Vitreous Haemorrhage |
4.7% |
| Multi-organ Failure |
3.9% |
| Sepsis |
3.9% |
| Vomiting |
3.9% |
| Death |
3.1% |
| Fall |
3.1% |
| Gastrointestinal Haemorrhage |
3.1% |
| Myalgia |
3.1% |
| Neutropenic Sepsis |
3.1% |
| Rhabdomyolysis |
3.1% |
| Subdural Haematoma |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.6% |
| Drug Use For Unknown Indication |
18.4% |
| Hypertension |
8.6% |
| Rheumatoid Arthritis |
4.8% |
| Diabetes Mellitus |
3.8% |
| Prophylaxis |
3.1% |
| Blood Cholesterol Increased |
2.8% |
| Depression |
2.6% |
| Pain |
2.1% |
| Cerebrovascular Accident |
1.9% |
| Hypercholesterolaemia |
1.9% |
| Osteoporosis |
1.9% |
| Transient Ischaemic Attack |
1.8% |
| Multiple Myeloma |
1.6% |
| Anticoagulant Therapy |
1.5% |
| Postoperative Care |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Atrial Fibrillation |
1.3% |
| Schizophrenia |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.2% |
|
| Vomiting |
11.2% |
| Transient Ischaemic Attack |
10.5% |
| Rhabdomyolysis |
8.3% |
| Death |
6.7% |
| Pneumonia |
5.4% |
| Renal Failure |
5.4% |
| Thrombocytopenia |
5.4% |
| Cerebrovascular Accident |
4.5% |
| Urinary Tract Infection |
4.5% |
| Vision Blurred |
4.5% |
| Hypoglycaemia |
4.2% |
| Syncope |
4.2% |
| Drug Interaction |
3.8% |
| Weight Decreased |
3.5% |
| Nausea |
3.2% |
| Pancytopenia |
3.2% |
| Wound Infection |
3.2% |
| Fall |
2.9% |
| International Normalised Ratio Increased |
2.9% |
| Hypertonia |
2.6% |
|
| Interacting |
| Drug Use For Unknown Indication |
46.7% |
| Anticoagulant Therapy |
20.0% |
| Atrial Fibrillation |
6.7% |
| Cerebrovascular Accident |
6.7% |
| Kawasaki's Disease |
6.7% |
| Product Used For Unknown Indication |
6.7% |
| Hip Arthroplasty |
3.3% |
| Thrombosis Prophylaxis |
3.3% |
|
| Vitreous Haemorrhage |
40.0% |
| Drug Interaction |
26.7% |
| Gastric Haemorrhage |
6.7% |
| Haemoglobin Decreased |
6.7% |
| Loss Of Consciousness |
6.7% |
| Ovarian Haemorrhage |
6.7% |
| Shock Haemorrhagic |
6.7% |
|
